NCT00239005View on ClinicalTrials.gov

Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

March 31, 2008

Conditions
Renal Transplant
Interventions
DRUG

Enteric-Coated Mycophenolate Sodium (EC-MPS)

DRUG

Mycophenolate Mofetil (MMF)

Trial Locations (1)

Unknown

Novartis Investigative Site, Nottingham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT00239005 - Enteric-Coated Mycophenolate Sodium on Quality of Life in Patients With Gastrointestinal Symptoms Related to Mycophenolate Mofetil Therapy After Kidney Transplantation | Biotech Hunter | Biotech Hunter